Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AKT
>>
Phase 1
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
SY-007
/ Yabao Pharma
CD8+NKG2D+ AKT cell immunotherapy
/ iCELL Biotechnology
DFN-529
/ CervoMed
GSK690693
/ GSK
NTQ1062
/ Sino Biopharm
PCUR-101
/ Pellficure
luxeptinib
(CG-806) / Aptose Biosci
AT13148
/ Otsuka
BAY 1125976
/ Bayer
HRS7415
/ Jiangsu Hengrui Pharma
ME-143
/ MEI
OB318
/ Microbio
SR13668
/ SRI International
TAS0612
/ Otsuka
VAD044
/ Vaderis
XL418
/ Exelixis
misetionamide
(GP-2250) / Panavance Therap
rupitasertib
(DIACC3010) / Evexta Bio
vevorisertib
(ARQ 751) / Merck (MSD)
